A remarkable finding, was the upregulation of the protein delta homolog 1 (DLK1), which is of great interest since it has been shown to inhibit adipogenesis and increase the expression of PPARs, thus proposed as therapeutic target for the treatment of obesity and diabetes (33). The gene discussed is DLK1; the disease is obesity due to melanocortin 4 receptor deficiency.